PhRMA Comment: Medical Product Communications That Are Consistent With the FDA-Required Labeling—Questions and Answers
PhRMA
4/19/2017 12:00:00 AM
Share This
PhRMA's comments on the FDA's draft guidance entitled “Medical Product Communications That Are Consistent With the FDA-Required Labeling—Questions and Answers” (“Draft Guidance”).